Akebia Therapeutics
AKBA
#6829
Rank
โ‚ฌ0.40 B
Marketcap
1,57ย โ‚ฌ
Share price
-8.27%
Change (1 day)
14.01%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2024 (TTM): -โ‚ฌ64.52 Million

According to Akebia Therapeutics's latest financial reports the company's current earnings are โ‚ฌ0.16 Billion. a decrease over its 2023 earnings that were of -โ‚ฌ47.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ63.07 Million33.68%
2023 -โ‚ฌ47.18 Million-45.12%
2022 -โ‚ฌ85.98 Million-66.55%
2021 -โ‚ฌ0.26 Billion-26.24%
2020 -โ‚ฌ0.35 Billion33.94%
2019 -โ‚ฌ0.27 Billion66.52%
2018 -โ‚ฌ0.16 Billion123.53%
2017 -โ‚ฌ69.89 Million-43.34%
2016 -โ‚ฌ0.13 Billion123.58%
2015 -โ‚ฌ55.17 Million63.95%
2014 -โ‚ฌ33.65 Million181.24%
2013 -โ‚ฌ11.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ4.18 B-6,740.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ12.39 B-19,751.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ15.84 B-25,228.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.11 Billion 71.73%๐Ÿ‡บ๐Ÿ‡ธ USA